Adopting AI-Driven Automation in Pharmacovigilance AND Achieving a Compelling ROI
-------------------------
Arietta.ai, a leader in life science Applied AI solutions, is slated to present at the 35th Pharmacovigilance 2024 Conference in Boston, MA on May 3, 2024. Tim Howard, CEO of Arietta.ai, will delve into the pivotal role accelerated ROI plays in achieving a successful initial rollout of advanced AI by pharmacovigilance departments.
"Adapting to executives' expectations regarding AI adoption is pivotal for strategic alignment within organizations. By approaching Applied AI integration in drug safety with a focused lens, we can achieve significant process enhancements while realizing a significant ROI within 12 months," commented Tim Howard.
PV leaders are best served by de-emphasizing the transformative potential of Advanced AI and focusing on the pragmatic benefits of realized time and cost savings and building trust in the underlying AI models. Quick wins that reinforce AI’s role to assist, and not replace, medical experts establish a foundation for long term success and innovation.
"The adoption of LucidPV as an Applied AI point solution for pharmacovigilance supports organizational objectives and provides tangible evidence of the profound impact focused AI solutions can have on overall business success," remarked James Brooks, Chairman of Arietta.ai.
Tim joins other pharmacovigilance and technology leaders to discuss prevalent challenges in drug safety data collection, analysis, signal detection, and reporting. The event provides a valuable platform for networking, knowledge exchange, and professional development.
Tim's presentation is scheduled for Friday, May 3rd, at 9:40 am, followed by a Q&A session and networking opportunities. For further inquiries or to schedule a meeting, contact us here: https://lnkd.in/gUtBQish. Additional details about the conference are available at https://lnkd.in/eypUV5y7.
Great opportunity 👍🏻😊